EV
Evolent Health, Inc.
EVH · NYSE
$4.19 +0.36% (+$0.02)
1M -4.99%
Market Cap $470.7M
P/E Ratio -
Div. Yield -
ROE 99.16%
Bulios Fair Price
$5.45
30.2% upside
Current Price
$4.19
Undervalued Fair Value Overvalued
According to Bulios Fair Price, EVH is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
71 /100
Cheap P/S 0.22x
P/B 1.23x
P/FCF 27.78x
Growth
57 /100
Stable Rev. growth 11.54%
Book val. growth 21.53%
EPS growth N/A
Profitability
6 /100
Weak Gross margin 12.92%
Net margin 24.08%
FCF margin 0.81%
Quality
13 /100
Poor ROIC 1.95%
ROE 99.16%
Asset turnover 1.06x
Debt
13 /100
High Debt/Equity 2.53x
Current ratio 1.24x
Int. coverage -6.26x
Stability
29 /100
Unstable Beta 0.84x
Rev. volatility 37.85%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about EVH
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Seth Barrie Blackley
Employees
4,200
Headquarters
Arlington
Upcoming events
05 NOV
Earnings
Upcoming earnings report